Side-by-side comparison of AI visibility scores, market position, and capabilities
Hsinchu Taiwan global foundry leader (NYSE: TSM) at $87.1B FY2024 revenue (+34%); AI chip revenue 3x growth with N2 2nm production 2025 and Arizona/Japan expansion serving Apple/NVIDIA competing with Samsung Foundry.
Taiwan Semiconductor Manufacturing Company (TSMC) is a Hsinchu, Taiwan-headquartered pure-play semiconductor foundry — publicly traded on the New York Stock Exchange (NYSE: TSM) and Taiwan Stock Exchange (TWSE: 2330) at approximately $800+ billion market capitalization — operating as the world's largest contract chipmaker with 60%+ global foundry market share, manufacturing semiconductors for Apple, NVIDIA, AMD, Qualcomm, Broadcom, and 500+ other fabless chip design companies. In FY2024, TSMC generated $87.1 billion in revenue (+34% year-over-year) with AI-related chip revenue growing 3x annually, reflecting the GPU and custom AI accelerator demand from hyperscalers. In 2025, TSMC's 2-nanometer (N2) process technology entered volume production (the world's most advanced at-scale semiconductor manufacturing), while the Arizona Fab 21 Phase 1 (4nm/N4P) began production in late 2024 and the Kumamoto, Japan fab opened in 2024. CEO C.C. Wei. Founded 1987 by Morris Chang, who pioneered the pure-play foundry model that separated chip design from manufacturing.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.